marketcaparena

TARS

Tarsus Pharmaceuticals, Inc.

Company overview

Market capitalization
$3.37B
Employees
370
Latest publication
2026-09-29
About Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company offers XDEMVY, a lotilaner ophthalmic solution for the treatment of demodex blepharitis caused by the infestation of Demodex mites. It sells its products to specialty pharmacies and distributors, as well as clinics, hospitals, pharmacies, and federal healthcare programs. The company also develops TP-04, a sterile aqueous gel formulation of lotilaner in Phase 2 trial for the treatment of ocular rosacea; and TP-05, an oral tablet formulation of lotilaner in Phase 2 trial for the prevention of Lyme disease, as well as in pre-clinical studies for community malaria reduction. In addition, it is developing the lotilaner active pharmaceutical ingredient (API) to address diseases in human medicine, including eye care and infectious disease prevention. The company has a development and license agreement with Xi An Grand Chang An Pharmaceutical Co., Ltd. for the development and commercialization of TP-03 in China for the treatment of Demodex blepharitis and meibomian gland disease. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ4 20222022-12-31 · USDQ3 20222022-09-30 · USDQ2 20222022-06-30 · USDQ1 20222022-03-31 · USDQ4 20212021-12-31 · USDQ3 20212021-09-30 · USDQ2 20212021-06-30 · USD
Total Revenue173,912,000USD10,000,000USD0USD15,277,000USD539,000USD338,000USD1,240,000USD22,017,000USD
Cost Of Revenue12,113,000USD400,000USD211,000USD522,000USD33,000USD-24,000USD65,000USD737,000USD
Gross Profit161,799,000USD9,600,000USD-211,000USD14,755,000USD506,000USD362,000USD1,175,000USD21,280,000USD
Research Development31,010,000USD10,028,000USD10,912,000USD9,603,000USD12,081,000USD8,038,000USD10,209,000USD7,204,000USD
Selling General Administrative150,697,000USD14,633,000USD11,994,000USD10,376,000USD7,946,000USD6,772,000USD6,671,000USD6,794,000USD
Total Operating Expenses181,707,000USD24,661,000USD22,695,000USD19,979,000USD20,027,000USD14,810,000USD16,880,000USD13,998,000USD
Operating Income-19,908,000USD-15,061,000USD-22,906,000USD-5,224,000USD-19,521,000USD-14,448,000USD-15,705,000USD7,282,000USD
Total Other Income Expense Net4,073,000USD1,462,000USD390,000USD-519,000USD-716,000USD-349,000USD-333,000USD-908,000USD
Interest Expense2,156,000USD692,000USD633,000USD544,000USD316,000USD12,000USD8,000USD7,000USD
Income Before Tax-15,835,000USD-13,599,000USD-22,516,000USD-5,743,000USD-20,237,000USD-14,797,000USD-16,038,000USD6,374,000USD
Income Tax Expense2,716,000USD-521,000USD-5,000USD519,000USD1,000USD54,000USD-341,000USD29,000USD
Net Income-18,551,000USD-13,599,000USD-22,511,000USD-5,743,000USD-20,238,000USD-14,851,000USD-15,697,000USD6,299,000USD
Interest Income—2,127,000USD1,061,000USD—————
Net Interest Income—1,435,000USD428,000USD-247,000USD-316,000USD12,000USD8,000USD7,000USD
Tax Provision—0USD-5,000USD0USD1,000USD54,000USD-341,000USD29,000USD
Net Income From Continuing Ops—-13,599,000USD-22,511,000USD-5,743,000USD-20,238,000USD-14,851,000USD-15,697,000USD6,345,000USD
Ebit—-12,907,000USD-21,929,000USD-5,199,000USD-19,921,000USD-14,797,000USD-16,038,000USD6,374,000USD
Ebitda—-12,809,000USD-21,835,000USD-5,107,000USD-19,880,000USD-14,757,000USD-15,955,000USD6,543,000USD
Depreciation And Amortization—98,000USD94,000USD92,000USD41,000USD40,000USD83,000USD169,000USD
Reconciled Depreciation—98,000USD94,000USD92,000USD41,000USD40,000USD83,000USD169,000USD
Non Operating Income Net Other—-1,034,000USD1,023,000USD-272,000USD-400,000USD-361,000USD-341,000USD-915,000USD
Net Income Applicable To Common Shares—-13,599,000USD-22,511,000USD-5,743,000USD-20,238,000USD-14,851,000USD-15,697,000USD6,345,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20222022-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Revenue25,816,000USD33,432,000USD0USD0USD
Cost Of Revenue955,000USD246,000USD74,000USD1,000USD
Gross Profit24,861,000USD-246,000USD-74,000USD-1,000USD
Research Development42,624,000USD18,826,000USD3,162,000USD901,000USD
Selling General Administrative44,949,000USD8,172,000USD1,136,000USD449,000USD
Total Operating Expenses87,573,000USD26,737,000USD4,224,000USD1,349,000USD
Operating Income-62,712,000USD-26,983,000USD-4,298,000USD-1,350,000USD
Interest Income3,499,000USD188,000USD——
Interest Expense2,064,000USD188,000USD40,000USD0USD
Net Interest Income1,300,000USD188,000USD-40,000USD32,000USD
Income Before Tax-62,095,000USD-26,810,000USD-4,669,000USD-1,318,000USD
Income Tax Expense-4,000USD1,000USD1,000USD1,000USD
Tax Provision-4,000USD1,000USD1,000USD1,000USD
Net Income-62,091,000USD-26,811,000USD-4,670,000USD-1,319,000USD
Net Income From Continuing Ops-62,091,000USD-26,811,000USD-4,670,000USD-1,319,000USD
Ebit-60,031,000USD-26,810,000USD-4,629,000USD-1,318,000USD
Ebitda-59,705,000USD-26,564,000USD-4,555,000USD-1,317,000USD
Depreciation And Amortization326,000USD246,000USD74,000USD1,000USD
Reconciled Depreciation325,000USD246,000USD74,000USD1,000USD
Total Other Income Expense Net617,000USD173,000USD-371,000USD32,000USD
Non Operating Income Net Other-683,000USD———
Net Income Applicable To Common Shares-62,091,000USD-26,811,000USD-4,670,000USD-1,319,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets611,142,000USD581,135,000USD562,158,000USD534,561,000USD494,994,000USD500,750,000USD376,991,000USD376,300,000USD
Short Term Investments245,095,000USD286,540,000USD233,627,000USD289,113,000USD284,495,000USD232,129,000USD196,557,000USD140,742,000USD
Long Term Investments6,682,000USD3,870,000USD3,870,000USD3,000,000USD3,000,000USD3,000,000USD3,000,000USD3,000,000USD
Total Current Assets561,989,000USD537,229,000USD522,782,000USD501,704,000USD474,429,000USD480,773,000USD356,705,000USD357,117,000USD
Other Non Current Assets660,000USD———————
Total Liabilities264,410,000USD———————
Total Current Liabilities175,753,000USD143,508,000USD135,695,000USD117,050,000USD90,253,000USD86,308,000USD80,612,000USD65,868,000USD
Other Non Current Liabilities15,895,000USD———————
Total Stockholder Equity346,732,000USD348,951,000USD343,426,000USD335,082,000USD332,612,000USD342,458,000USD224,534,000USD237,484,000USD
Total Equity Including Noncontrolling Interest346,732,000USD———————
Long Term Debt72,762,000USD72,597,000USD72,438,000USD72,281,000USD72,129,000USD71,984,000USD71,845,000USD71,708,000USD
Net Receivables96,028,000USD117,207,000USD87,109,000USD74,336,000USD60,240,000USD64,153,000USD48,059,000USD30,304,000USD
Inventory4,377,000USD4,572,000USD4,372,000USD3,836,000USD3,873,000USD2,705,000USD2,620,000USD2,846,000USD
Property Plant Equipment Net30,400,000USD27,666,000USD21,745,000USD15,979,000USD3,411,000USD3,180,000USD2,866,000USD4,195,000USD
Intangible Assets6,885,000USD7,126,000USD7,366,000USD7,606,000USD7,846,000USD8,086,000USD8,326,000USD8,567,000USD
Accounts Payable40,141,000USD24,131,000USD16,387,000USD40,642,000USD28,075,000USD28,383,000USD27,739,000USD26,815,000USD
Common Stock6,000USD6,000USD6,000USD6,000USD6,000USD6,000USD6,000USD6,000USD
Retained Earnings-452,146,000USD-433,595,000USD-426,628,000USD-418,255,000USD-405,670,000USD-385,330,000USD-360,210,000USD-337,097,000USD
Accumulated Other Comprehensive Income-557,000USD-298,000USD381,000USD289,000USD39,000USD85,000USD179,000USD346,000USD
Other Current Assets—26,718,000USD14,033,000USD21,695,000USD29,173,000USD5,999,000USD14,650,000USD7,015,000USD
Total Liab—232,184,000USD218,732,000USD199,479,000USD162,382,000USD158,292,000USD152,457,000USD138,816,000USD
Other Current Liab—119,377,000USD119,308,000USD76,328,000USD61,861,000USD57,541,000USD52,265,000USD38,422,000USD
Capital Stock—6,000USD6,000USD6,000USD6,000USD6,000USD6,000USD6,000USD
Cash—102,192,000USD183,641,000USD112,724,000USD96,648,000USD175,787,000USD94,819,000USD176,210,000USD
Cash And Short Term Investments—388,732,000USD417,268,000USD401,837,000USD381,143,000USD407,916,000USD291,376,000USD316,952,000USD
Net Debt—-13,516,000USD-90,005,000USD-30,215,000USD-24,202,000USD-103,419,000USD-22,366,000USD-103,871,000USD
Short Long Term Debt Total—88,676,000USD93,636,000USD82,509,000USD72,446,000USD72,368,000USD72,453,000USD72,339,000USD
Property Plant Equipment Gross—29,961,000USD23,843,000USD18,608,000USD5,820,000USD5,376,000USD4,842,000USD5,978,000USD
Common Stock Shares Outstanding—42,956,973shares42,784,688shares42,607,717shares42,360,452shares39,345,359shares38,560,907shares38,381,968shares
Non Current Assets Total—43,905,999USD39,376,000USD32,857,000USD20,565,000USD19,977,000USD20,286,000USD19,183,000USD
Non Current Liabilities Total—88,675,999USD83,037,000USD82,429,000USD72,129,000USD71,984,000USD71,845,000USD72,948,000USD
Non Current Liabilities Other—16,079,000USD10,599,000USD10,148,000USD———1,240,000USD
Non Currrent Assets Other—3,242,999USD6,395,000USD3,709,000USD6,308,000USD5,711,000USD6,094,000USD3,421,000USD
Net Working Capital—393,721,000USD387,087,000USD384,654,000USD384,176,000USD394,465,000USD276,093,000USD291,249,000USD
Unclassified Non Current Assets—2,001,000USD—2,563,000USD————
Unclassified Equity—782,832,000USD769,661,000USD753,036,000USD738,231,000USD727,691,000USD584,553,000USD574,223,000USD
Short Term Debt———80,000USD317,000USD384,000USD608,000USD631,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets562,158,000USD376,991,000USD265,491,000USD227,863,000USD178,907,000USD171,972,000USD58,316,000USD2,389,000USD
Intangible Assets7,366,000USD8,326,000USD3,867,000USD—————
Other Current Assets14,033,000USD14,650,000USD7,868,000USD4,767,000USD4,045,000USD2,506,000USD42,000USD24,000USD
Total Liab218,732,000USD152,457,000USD68,503,000USD34,963,000USD12,177,000USD5,992,000USD64,321,000USD3,743,000USD
Total Stockholder Equity343,426,000USD224,534,000USD196,988,000USD192,900,000USD166,730,000USD165,980,000USD-6,005,000USD-1,354,000USD
Other Current Liab119,308,000USD52,265,000USD18,766,000USD9,196,000USD7,261,000USD2,868,000USD299,000USD4,000USD
Common Stock6,000USD6,000USD5,000USD5,000USD4,000USD4,000USD2,000USD1,000USD
Capital Stock6,000USD6,000USD5,000USD5,000USD4,000USD4,000USD2,000USD1,000USD
Retained Earnings-426,628,000USD-360,210,000USD-244,656,000USD-108,763,000USD-46,672,000USD-32,845,000USD-6,034,000USD-1,364,000USD
Cash183,641,000USD94,819,000USD224,947,000USD71,660,000USD171,332,000USD168,129,000USD57,952,000USD2,355,000USD
Cash And Short Term Investments417,268,000USD291,376,000USD227,442,000USD217,026,000USD171,815,000USD168,129,000USD57,952,000USD2,355,000USD
Total Current Assets522,782,000USD356,705,000USD256,131,000USD225,375,000USD175,952,000USD170,655,000USD58,030,000USD2,383,000USD
Total Current Liabilities135,695,000USD80,612,000USD36,936,000USD15,429,000USD11,478,000USD5,387,000USD819,000USD179,000USD
Net Debt-90,005,000USD-22,366,000USD-194,730,000USD-51,453,000USD-169,441,000USD-167,298,000USD-57,788,000USD-2,355,000USD
Short Long Term Debt Total93,636,000USD72,453,000USD30,217,000USD20,207,000USD1,891,000USD831,000USD164,000USD—
Long Term Debt72,438,000USD71,845,000USD29,819,000USD19,434,000USD————
Long Term Investments3,870,000USD3,000,000USD631,000USD371,000USD0USD———
Short Term Investments233,627,000USD196,557,000USD2,495,000USD145,366,000USD483,000USD0USD——
Net Receivables87,109,000USD48,059,000USD17,714,000USD3,582,000USD92,000USD20,000USD36,000USD4,000USD
Inventory4,372,000USD2,620,000USD3,107,000USD4,762,233USD175,684,140USD—20,000USD—
Accounts Payable16,387,000USD27,739,000USD17,772,000USD5,498,000USD2,856,000USD2,237,000USD456,000USD175,000USD
Property Plant Equipment Net21,745,000USD2,866,000USD3,348,000USD1,532,000USD1,829,000USD1,236,000USD280,000USD6,000USD
Property Plant Equipment Gross23,843,000USD4,842,000USD4,638,000USD957,000USD1,829,000USD548,000USD280,000USD6,000USD
Accumulated Other Comprehensive Income381,000USD179,000USD-2,000USD-74,000USD—-171,972,000USD-63,402,000USD-1,000USD
Common Stock Shares Outstanding41,784,014shares37,604,538shares29,383,276shares24,619,700shares20,554,086shares20,323,201shares19,509,014shares4,285,262shares
Non Current Assets Total39,376,000USD20,286,000USD9,360,000USD2,488,000USD2,955,000USD1,317,000USD286,000USD6,000USD
Non Current Liabilities Total83,037,000USD71,845,000USD31,567,000USD19,534,000USD699,000USD605,000USD63,502,000USD3,564,000USD
Non Current Liabilities Other10,599,000USD—1,748,000USD100,000USD699,000USD605,000USD——
Non Currrent Assets Other6,395,000USD6,094,000USD1,514,000USD585,000USD463,000USD81,000USD6,000USD—
Net Working Capital387,087,000USD276,093,000USD219,195,000USD209,946,000USD164,474,000USD165,268,000USD57,211,000USD2,204,000USD
Unclassified Equity769,661,000USD584,553,000USD441,636,000USD301,727,000USD213,394,000USD370,789,000USD63,427,000USD—
Short Term Debt—608,000USD398,000USD721,000USD1,306,000USD282,000USD64,000USD—
Other Assets——1USD477,000USD178,907USD769,000USD6,000USD—
Other Liab———48,000USD114,000USD56,000USD——
Net Tangible Assets———192,900,000USD166,730,000USD165,980,000USD-6,005,000USD-1,354,000USD
Unclassified Current Assets———-4,762,233USD-175,684,140USD———
Current Deferred Revenue————697,000USD———
Unclassified Non Current Liabilities——————63,502,000USD3,564,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income-6,967,000USD-8,373,000USD-12,585,000USD-20,340,000USD-25,120,000USD-23,113,000USD-23,420,000USD-33,290,000USD
Depreciation437,000USD443,000USD400,000USD453,000USD460,000USD432,000USD284,000USD239,000USD
Stock Based Compensation11,967,000USD14,314,000USD12,243,000USD8,233,000USD6,930,000USD7,403,000USD7,415,000USD7,481,000USD
Other Non Cash Items-613,000USD-629,000USD-1,129,000USD-1,378,000USD-1,011,000USD-1,177,000USD8,732,000USD914,000USD
Change To Account Receivables-30,098,000USD-12,773,000USD-14,096,000USD3,913,000USD-16,095,000USD-17,755,000USD588,000USD521,000USD
Change To Inventory-196,000USD-536,000USD37,000USD-1,168,000USD-84,000USD227,000USD-652,000USD-692,000USD
Change In Working Capital-29,476,000USD13,575,000USD19,328,000USD-16,355,000USD-1,910,000USD-5,727,000USD-1,663,000USD10,252,000USD
Total Cash From Operating Activities-24,652,000USD19,330,000USD18,257,000USD-29,387,000USD-20,651,000USD-22,182,000USD-8,652,000USD-14,404,000USD
Capital Expenditures-5,818,000USD-6,358,000USD-1,910,000USD-1,001,000USD-590,000USD-5,072,000USD-282,000USD-1,039,000USD
Free Cash Flow-30,470,000USD12,972,000USD16,347,000USD-30,388,000USD-21,241,000USD-27,254,000USD-8,934,000USD-15,443,000USD
Investments-52,744,000USD55,632,000USD-4,743,000USD-51,704,000USD-34,942,000USD-59,574,000USD3,128,000USD-40,525,000USD
Total Cashflows From Investing Activities-58,562,000USD49,274,000USD-4,743,000USD-51,704,000USD-34,942,000USD-59,574,000USD3,128,000USD-40,525,000USD
Total Cash From Financing Activities1,204,000USD2,312,000USD2,562,000USD1,952,000USD136,562,000USD2,927,000USD639,000USD42,319,000USD
Issuance Of Capital Stock0USD0USD0USD-354,000USD135,125,000USD0USD-9,408,000USD-274,000USD
Change In Cash-82,009,000USD70,916,000USD16,076,000USD-79,139,000USD80,969,000USD-78,829,000USD-4,885,000USD-12,610,000USD
Begin Period Cash Flow184,201,000USD115,287,000USD99,211,000USD178,350,000USD97,381,000USD176,210,000USD181,095,000USD193,705,000USD
End Period Cash Flow102,192,000USD186,203,000USD115,287,000USD99,211,000USD178,350,000USD97,381,000USD176,210,000USD181,095,000USD
Other Cashflows From Financing Activities1,204,000USD2,312,000USD2,562,000USD2,306,000USD1,437,000USD31,877,000USD682,000USD-31,877,000USD
Net Borrowings—0USD0USD——0USD0USD—
Other Cashflows From Investing Activities——-2,833,000USD——-5,000,000USD3,000,000USD-3,000,000USD
Unclassified Investing Cash Flow——4,743,000USD1,001,000USD—10,072,000USD-2,718,000USD4,039,000USD
Unclassified Financing Cash Flow—————-28,950,000USD-6,728,000USD80,881,000USD
Sale Purchase Of Stock——————6,685,000USD-6,685,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-66,418,000USD-115,554,000USD-135,893,000USD-62,091,000USD-13,827,000USD-26,811,000USD-4,670,000USD-1,319,000USD
Depreciation1,816,000USD1,225,000USD877,000USD325,000USD312,000USD96,000USD37,000USD1,000USD
Stock Based Compensation41,720,000USD27,818,000USD19,830,000USD13,460,000USD8,455,000USD839,000USD18,000USD9,000USD
Other Non Cash Items-4,207,000USD-360,000USD-2,613,000USD227,000USD7,436,000USD3,280,000USD457,000USD-116,000USD
Change To Account Receivables-39,051,000USD-30,139,000USD-14,131,000USD-3,490,000USD-73,000USD16,000USD-32,000USD-4,000USD
Change To Inventory-1,751,000USD-2,046,000USD-3,107,000USD3,490,000USD73,000USD-16,000USD32,000USD—
Change In Working Capital14,638,000USD3,844,000USD306,000USD-951,000USD1,372,000USD1,458,000USD485,000USD126,000USD
Total Cash From Operating Activities-12,451,000USD-83,027,000USD-117,493,000USD-49,030,000USD3,748,000USD-21,138,000USD-3,673,000USD-1,183,000USD
Capital Expenditures-9,859,000USD-1,567,000USD-5,502,000USD-506,000USD-586,000USD-456,000USD-175,000USD-7,000USD
Free Cash Flow-22,310,000USD-84,594,000USD-122,995,000USD-49,536,000USD3,162,000USD-21,594,000USD-3,848,000USD-1,190,000USD
Investments-32,256,000USD-199,195,000USD35,535,000USD-144,123,000USD-586,000USD-456,000USD-175,000USD-7,000USD
Total Cashflows From Investing Activities-42,115,000USD-199,195,000USD140,604,000USD-144,629,000USD-586,000USD-456,000USD-175,000USD-7,000USD
Net Borrowings0USD75,000,000USD10,000,000USD-875,000USD20,000,000USD20,000,000USD1,989,000USD1,989,000USD
Total Cash From Financing Activities143,388,000USD154,656,000USD130,176,000USD93,987,000USD21,000USD131,771,000USD59,445,000USD3,564,000USD
Issuance Of Capital Stock134,771,000USD98,287,000USD99,377,000USD74,352,000USD91,457,000USD131,429,000USD57,456,000USD3,564,000USD
Change In Cash88,822,000USD-127,566,000USD153,287,000USD-99,672,000USD3,183,000USD110,177,000USD55,597,000USD2,374,000USD
Begin Period Cash Flow97,381,000USD224,947,000USD71,660,000USD171,332,000USD168,149,000USD57,972,000USD2,375,000USD1,000USD
End Period Cash Flow186,203,000USD97,381,000USD224,947,000USD71,660,000USD171,332,000USD168,149,000USD57,972,000USD2,375,000USD
Other Cashflows From Financing Activities143,388,000USD-18,631,000USD1,577,000USD-365,000USD21,000USD40,098,000USD57,456,000USD3,564,000USD
Unclassified Financing Cash Flow-134,771,000USD—19,222,000USD20,290,000USD-20,324,000USD71,701,000USD-57,456,000USD-5,553,000USD
Other Cashflows From Investing Activities—-5,000,000USD-4,000,000USD-144,123,000USD————
Unclassified Investing Cash Flow—6,567,000USD114,571,000USD144,123,000USD————
Change To Liabilities———3,475,000USD5,753,000USD3,240,000USD245,000USD131,000USD
Sale Purchase Of Stock———74,937,000USD324,000USD-28,000USD——
Cash And Cash Equivalents Changes———-99,672,000USD3,183,000USD110,177,000USD——
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q2 2026Quarterly · 2026-06-30ProductLicense And Collaboration0USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductProduct173,912,000USDDisclosure
Q1 2026Quarterly · 2026-03-31ProductLicense And Collaboration16,667,000USD0001819790-26-000038
Q1 2026Quarterly · 2026-03-31ProductProduct145,387,000USD0001819790-26-000038
Q4 2025Quarterly · 2025-12-31ProductLicense And Collaboration0USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductProduct151,668,000USDLegacy provider
FY 2025Yearly · 2025-12-31ProductLicense And Collaboration0USD0001819790-26-000019
FY 2025Yearly · 2025-12-31ProductProduct451,360,000USD0001819790-26-000019
Q3 2025Quarterly · 2025-09-30ProductLicense And Collaboration0USD0001819790-25-000121
Q3 2025Quarterly · 2025-09-30ProductProduct118,697,000USD0001819790-25-000121
Q2 2025Quarterly · 2025-06-30ProductLicense And Collaboration0USD0001819790-25-000108
Q2 2025Quarterly · 2025-06-30ProductProduct102,660,000USD0001819790-25-000108
Q1 2025Quarterly · 2025-03-31ProductLicense And Collaboration0USD0001819790-26-000038
Q1 2025Quarterly · 2025-03-31ProductProduct78,335,000USD0001819790-26-000038
Q4 2024Quarterly · 2024-12-31ProductLicense And Collaboration0USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductProduct66,408,000USDLegacy provider
FY 2024Yearly · 2024-12-31ProductLicense And Collaboration2,894,000USD0001819790-26-000019
FY 2024Yearly · 2024-12-31ProductProduct180,059,000USD0001819790-26-000019
Q3 2024Quarterly · 2024-09-30ProductLicense And Collaboration0USD0001819790-24-000129
Q3 2024Quarterly · 2024-09-30ProductLicense And Collaboration Other0USD0001819790-24-000129
Q3 2024Quarterly · 2024-09-30ProductProduct48,118,000USD0001819790-24-000129
FY 2023Yearly · 2023-12-31ProductLicense And Collaboration2,718,000USD0001819790-26-000019
FY 2023Yearly · 2023-12-31ProductProduct14,729,000USD0001819790-26-000019
FY 2022Yearly · 2022-12-31ProductLicense And Collaboration Other0USD0001819790-24-000018
FY 2022Yearly · 2022-12-31ProductLicense Fees And Collaboration25,816,000USD0001819790-24-000018
FY 2022Yearly · 2022-12-31ProductProduct0USD0001819790-24-000018
FY 2021Yearly · 2021-12-31ProductCollaboration Revenue3,960,000USD0001819790-23-000007
FY 2021Yearly · 2021-12-31ProductLicense And Service53,067,000USD0001819790-23-000007

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.